Abstract:Introduction Voxel based morphometry (VBM) is a neuroimaging analysis technique that allows investigation of focal differences in brain anatomy, using the statistical approach of so-called statistical parametric mapping [1,2]. Major depressive disorder (MDD) is a common and serious psychiatric illness. In past study, the authors have done many researches to reveal the change in grey matter [3-7]. However, the neurobiology of MDD is largely unknown. The purpose of the present study was to identify brain regions with gray matter volume and density changes with relative large MDD subjects and controls using optimized voxel-based morphometry. Material and Method Fifty one patients experiencing MDD (mean age = 34.6 ± 12.7, twenty five males and twenty eight females) according to the diagnostic criterion of DSM-IV, who had a score of 18 or greater on the 17-item Hamilton Depression Rating Scale (HAMD), and fifty two age and sex matched normal controls (mean age = 37.2 ± 16.1, twenty three males and twenty eight females) were recruited. MR scanning was carried out on a 3.0 TMR scanner (EXCITE, GE Signa, Milwaukee, USA). High resolution 3-dimensional T1-weighted (T1W) images were acquired employing a spoiled gradient recalled (SPGR) sequence with TR/TE = 8.5/3.4 ms, FA = 120, 156 axial slices with thickness = 1 mm, axial FOV 24 × 24 cm and data matrix = 256 × 256. Optimized voxel-based morphometry [2] was conducted using Statistical Parametric Mapping–2 (SPM2) (Welcome Department of Imaging Neuroscience, London [http://www.fil.ion.ucl.ac.uk/spm]). The voxel-based morphometry–2 toolbox, which implements the optimized voxel-based morphometry approach [2], was used for data preprocessing. Voxel-by-voxel-based comparisons of gray matter density and volume were performed between groups using two-sample t tests. The correlation between the regional gray matter changes and clinical symptom severity was examined. A corrected p value of less than 0.001 was deemed to be significant. Results Patients with MDD exhibited higher grey matter volume than normal controls in multiple brain regions including bilateral thalamus, left and right superior parietal lobule, right frontal lobe (Table 1, Figure 1 A, B and C). MDD patients also showed higher grey matter density than normal controls in bilateral thalamus (cluster level p < 0.001, corrected) (Table 1, Figure 1 D). No significant correlation between regional gray matter changes and HAMD scores was found after controlling for age, years of education and duration of illness.

Investigating the relationship between hippocampus/dentate gyrus volume and hypothalamus metabolism in participants with major depressive disorder

Altered Hippocampal Subfield Volumes in Major Depressive Disorder with and Without Anhedonia.

Volume Changes of the Subcortical Limbic Structures in Major Depressive Disorder Patients with and Without Anhedonia.

The association between gray matter volume in the hippocampal subfield and antidepressant efficacy mediated by abnormal dynamic functional connectivity

Plasma metabolites were associated with spatial working memory in major depressive disorder

Changes of brain morphometry in first-episode, drug-naïve, non-late-life adult patients with major depression: an optimized voxel-based morphometry study.

Brain Grey Matter Volume Alterations Associated with Antidepressant Response in Major Depressive Disorder.

A Proton Magnetic Resonance Spectroscopy Research on Hippocampus in Patients with Treatment-Resistant Depression

Hippocampal N-acetylaspartate and morning cortisol levels in drug-naive, first-episode patients with major depressive disorder: effects of treatment.

Hippocampal and parahippocampal volume and function predict antidepressant response in patients with major depression: A multimodal neuroimaging study

Hippocampal Granule Neuron Number and Dentate Gyrus Volume in Antidepressant-Treated and Untreated Major Depression

Altered brain connectivity with hippocampus in patients with major depressive disorder

Meta‐Analysis of Brain Volumetric Abnormalities in Patients with Remitted Major Depressive Disorder

Hippocampal volume changes after (R,S)-ketamine administration in patients with major depressive disorder and healthy volunteers

Reduced gray matter volume of the hippocampal tail in melancholic depression: evidence from an MRI study

Abnormal Hippocampal Subfields May Be Potential Predictors of Worse Early Response to Antidepressant Treatment in Drug‐Naïve Patients with Major Depressive Disorder

Cerebral Metabolism in Major Depressive Disorder: a Voxel-Based Meta-Analysis of Positron Emission Tomography Studies

Morphological Changes in Subregions of Hippocampus and Amygdala in Major Depressive Disorder Patients.

Depression, hippocampal volume changes, and cognitive decline in a clinical sample of older depressed outpatients and non-depressed controls

Morphometry of the Hippocampus Across the Adult Life-Span in Patients with Depressive Disorders: Association with Neuroticism

Regional gray matter changes in major depressive disorder : an optimized voxel-based morphometry study